openPR Logo
Press release

Wearable Injectors Market is on an Upward Growth Curve

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Wearable Injectors Market- (By Type of Device (Patch Pump / Injectors, Infusion Pump / Injectors), By Usability (Disposable, Reusable), By Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders, Other Disorders)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Wearable Injectors Market Size is valued at USD 4.16 Bn in 2023 and is predicted to reach USD 7.87 Bn by the year 2031 at a 8.44% CAGR during the forecast period for 2024-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2061

Wearable injectors are advanced drug delivery devices designed to adhere to the skin and administer prescribed medication doses in a controlled manner over a specific time frame-ranging from seconds to several hours. Unlike traditional insulin pumps, these devices are typically single-use and offer a more discreet and patient-friendly alternative for subcutaneous drug delivery.

The market for wearable injectors is experiencing robust growth, primarily driven by the increasing prevalence of chronic health conditions such as diabetes, cancer, cardiovascular diseases, and respiratory ailments. Furthermore, the growing adoption of biologic therapies-including monoclonal antibodies-has significantly contributed to the demand for these innovative delivery systems.

List of Prominent Players in the Wearable Injectors Market:
• CCBio
• CeQur
• Debiotech
• E3D Elcam Drug Delivery Devices
• Eli Lilly
• Enable Injections
• Gerresheimer
• Insulet
• Medtronic
• Medtrum Technologies
• Pharmasense
• Roche
• Sonceboz
• Weibel CDS
• West Pharmaceuticals
• SOOIL Development
• Becton, Dickinson and Company
• Johnson & Johnson Services, Inc.
• Elcam Drug Delivery Devices (Israel),
• Recipharm AB. (U.K),
• Stevanato Group (Italy),
• Sorrel Medical (Israel),
• Others

Market Dynamics:
Drivers-
The growing adoption of wearable injectors is largely driven by the limitations of traditional syringes and the risk of needle-stick injuries. These compact, easy-to-use devices eliminate the need for healthcare professional assistance, thereby reducing overall healthcare expenses. Their portability allows users to self-administer medication conveniently while going about daily routines at home or work.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/2061

Challenges:
One of the main barriers to the widespread adoption of wearable injectors is the lack of reimbursement in many developing countries. For example, India lacks formal guidelines and insurance coverage for wearable insulin pumps, placing the full financial burden on type 1 diabetes patients. This absence of reimbursement structures is expected to hinder market growth in these regions.

Regional Trends:
North America currently dominates the wearable injector market in terms of revenue and is anticipated to grow at a significant CAGR in the coming years. This growth is attributed to the high prevalence of chronic conditions-research shows that nearly 60% of Americans suffer from at least one chronic illness-and the availability of innovative biologic treatments.

Meanwhile, the Asia-Pacific region is emerging as a lucrative market for wearable injectors. Factors such as the increasing incidence of diabetes, cardiovascular diseases, and cancer, coupled with the expansion of healthcare infrastructure and a rising preference for home-based treatments, are fueling demand. Moreover, regulatory approvals for new biologics and a shift toward patient-centered care are expected to further drive market expansion.

Recent Developments:
• In April 2023, The FDA granted permission to Insulet Corporation for its most recent advancement, Omnipod GOTM, an insulin delivery apparatus authorised for individuals aged 18 or above diagnosed with type 2 diabetes, who generally administer daily injections of long-acting insulin.
• In June 2022, Enable Injections, Inc. (Enable) signed a development agreement with Genentech, a Roche Group company. Enable's enFuseTM will allow for the subcutaneous administration of high-volume medications.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2061

Segmentation of Wearable Injectors Market-
By Type of Device
• Patch Pump / Injectors
• Infusion Pump / Injectors

By Usability
• Disposable
• Reusable

By Therapeutic Area
• Autoimmune Disorders
• Cardiovascular Disorders
• Metabolic Disorders
• Neurological Disorders
• Oncological Disorders
• Other Disorders

By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Get More Information: @
https://www.insightaceanalytic.com/report/wearable-injectors-market/2061

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wearable Injectors Market is on an Upward Growth Curve here

News-ID: 4140232 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5.3% CAGR Amid Rising Awareness of PCOS and PMS
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North America, Europe, and Asia-Pacific
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, Pall Corporation, 3M Company, Waters Corporation.
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc.
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical

All 5 Releases


More Releases for Disorders

Disorders in Rehabilitation Lantana Recovery Rehab Offers Insights on Managing C …
Image: https://www.getnews.info/wp-content/uploads/2024/09/1725387183.jpeg Lantana Recovery is a top-rated addiction treatment center. In a recent update, the center shared strategies for addressing co-occurring disorders in rehab. New Milford, CT - In a website post, Lantana Recovery shared strategies for addressing co-occurring disorders in rehab. The drug rehab New Milford [https://www.google.com/maps?cid=2284086668056385519] noted that one effective strategy for managing these complex cases involves integrated treatment programs. These programs provide a comprehensive approach where a multidisciplinary team
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users. Download Sample PDF
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices. The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder
11-29-2018 | Health & Medicine
Fact.MR
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits. Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719 These vocal biomarkers are
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY